1. Home
  2. OMER vs GO Comparison

OMER vs GO Comparison

Compare OMER & GO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Omeros Corporation

OMER

Omeros Corporation

HOLD

Current Price

$11.85

Market Cap

894.8M

Sector

Health Care

ML Signal

HOLD

Logo Grocery Outlet Holding Corp.

GO

Grocery Outlet Holding Corp.

HOLD

Current Price

$9.56

Market Cap

941.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
OMER
GO
Founded
1994
1946
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Food Chains
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
894.8M
941.1M
IPO Year
2009
2019

Fundamental Metrics

Financial Performance
Metric
OMER
GO
Price
$11.85
$9.56
Analyst Decision
Strong Buy
Hold
Analyst Count
5
11
Target Price
$32.50
$15.27
AVG Volume (30 Days)
2.4M
2.4M
Earning Date
11-13-2025
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,571,346,000.00
Revenue This Year
N/A
$10.67
Revenue Next Year
N/A
$5.13
P/E Ratio
N/A
N/A
Revenue Growth
N/A
7.22
52 Week Low
$2.95
$8.96
52 Week High
$17.65
$19.41

Technical Indicators

Market Signals
Indicator
OMER
GO
Relative Strength Index (RSI) 46.02 45.35
Support Level $11.44 $9.06
Resistance Level $12.18 $9.67
Average True Range (ATR) 0.64 0.41
MACD -0.18 0.04
Stochastic Oscillator 13.72 51.48

Price Performance

Historical Comparison
OMER
GO

About OMER Omeros Corporation

Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders. The drug candidate in the pipeline of complement-targeted therapeutics is narsoplimab (OMS721), a proprietary, patented human monoclonal antibody targeting mannan-binding lectin-associated serine protease 2, the key activator of the lectin pathway of complement. Clinical development of narsoplimab is currently focused on hematopoietic stem cell transplant-associated thrombotic microangiopathy and immunoglobulin nephropathy.

About GO Grocery Outlet Holding Corp.

Grocery Outlet Holding Corp is a grocery store operator in the United States. It is a retailer of quality, name-brand consumables and fresh products sold through a network of independently operated stores. The stores are run by Entrepreneurial independent operators which create a neighborhood feel through personalized customer service and a localized product offering.

Share on Social Networks: